G7 Explores AI Access Deal With U.S. Amid Anthropic Restrictions 
HSBC Australia Faces A$35M Penalty Over Scam Protection Failures 
GM and Lockheed Martin Partner to Strengthen U.S. Defense Manufacturing Capacity 
SpaceX Surpasses Amazon in Market Value as Post-IPO Rally Accelerates 
Kingboard Holdings Shares Surge After HK$11.77 Billion Block Trade to Expand PCB and AI Supply Chain Business 
SoftBank Shares Drop as OpenAI Losses and Rising Costs Spark Investor Concerns 
Chinese Social Media Giant Xiaohongshu Eyes Hong Kong IPO at Over $70 Billion Valuation 
Trump Administration Delays DeepSeek and CXMT Trade Blacklist Designations Amid U.S.-China Tensions 
Qantas Unveils Wellness-Focused Nonstop Sydney-London Flights to Reduce Jet Lag 
BHP Shares Fall as Jansen Potash Project Costs Surge 
Samsung Gains Interest from BYD, Google, AMD as AI Chip Demand Strains TSMC Capacity 
Jio IPO Filing Nears as Reliance Targets $4 Billion Market Debut 
Saudi Aramco Explores Sulphur Business Stake Sale to Raise Billions 
Ukrainian Drone Makers Target Japan and Asia Defense Market 
Google’s Open-Source AI Data Center Cooling Design Raises Commoditization Concerns 
Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks 
John Jumper Leaves Google DeepMind for Anthropic Amid Intensifying AI Talent Race 
NORCROSS, Ga., Jan. 14, 2016 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that it will hold a conference call with debt investors on Tuesday, February 2, 2016, at 2:00 p.m. ET to discuss its fiscal 2016 second quarter results.
Interested debt investors and analysts should contact Immucor Investor Relations at [email protected] or 770-441-2051 for details.
About Immucor
Founded in 1982, Immucor is a global leader in transfusion and transplantation diagnostics that facilitate patient-donor compatibility. Our mission is to ensure that patients in need of blood, organs or stem cells get the right match that is safe, accessible and affordable. With the right match, we can transform a life together. For more information on Immucor, please visit our website at www.immucor.com.
CONTACT: Michele Howard 770-441-2051
